Semaglutide
Chronic weight management and other labeled uses vary by product
Evidence: Strong FDA-reviewed clinical evidence
Administration: Injection or oral; product-specific
Score 9.1/10Read Review →Evidence and regulatory context for peptide-based treatments connected to weight management.
Tirzepatide
Chronic weight management; other indications depend on product
Evidence: Strong FDA-reviewed clinical evidence
Administration: Weekly injection
Score 9.1/10Read Review →Liraglutide
Weight management or type 2 diabetes, depending on product
Evidence: Strong FDA-reviewed clinical evidence
Administration: Daily injection
Score 8.7/10Read Review →Established / approved options
Semaglutide, tirzepatide, and liraglutide have FDA-approved products with weight-management indications. Product, eligibility, and indication matter.
Being researched
No research peptide is promoted as a recommended weight-management treatment.
How to use this page
Established options appear before experimental compounds. Goal relevance never overrides regulatory status or evidence quality.
Next step
Open the relevant treatment review for sources, risks, contraindications, and evidence gaps.
MyPeptideQuest
Information only. Not medical advice. No dosing or self-treatment instructions are provided.